XRF Scientific (XRF) investor relations material

Technology and products

• Sample preparation and analysis technologies serve mining, manufacturing, commercial labs, research and education; applications include iron ore, gold, nickel, copper, cement, metals and glass, using XRF, ICP, fire assay and photon assay.

• Orbis crushers reduce 110 mm drill-core samples to 2 mm in one pass, with automated splitting, loader options and a design for continuous use in harsh mining conditions.

• Lab products include platinum labware, X-ray flux and fusion machines, plus recycling used platinum products into new items.

• XRTGA supports analysis of moisture, volatiles, ash, fixed carbon and loss on ignition; applications include mining, construction materials, food, plastics and agriculture.

• CGA elemental analysis covers carbon, sulphur, oxygen, nitrogen and hydrogen for quality control across metals, alloys, welding, magnetic materials and additive manufacturing.

FY26 highlights

• Strong mining and industrial demand, international sales growth in developing markets, particularly Asia, and continued growth in Orbis crusher sales.

• Acquired the CGA Elemental Analysis Instrument business from Bruker AXS SE on 23 April 2026 for upfront consideration of US$4m; opened offices in India and the US.

• FY26 revenue rose 8% YoY to $64.4m; adjusted NPBT increased 10% to $16.1m.

• NPAT increased 1% to $10.5m after acquisition and international-office startup costs; effective tax rate rose to 32% from 29%.

• Gross margin was 49.3% vs 48.4% in FY25; fully franked dividend was 4.5 cents per share, and Q4 adjusted PBT reached a record $4.7m on $17.2m revenue.

Balance sheet and cash flow

• Net cash position was $8.5m at FY26 year-end; cash and cash equivalents were $9.5m vs $12.2m in FY25.

• CGA acquisition was funded entirely in cash and added $6.2m to intangible assets, $1.0m to inventories and $1.4m to other payables for acquisition earnout liability.

• Operating cash inflow was $11.4m vs $10.1m in FY25; investing outflow was $8.1m, including $5.6m for the CGA acquisition.

• Financing cash outflow was $6.0m, including $5.0m paid for the FY25 dividend; cash ended the period at $9.5m.